medicines for europe Regulatory Affairs Conference 2026

ACCURIDS at medicines for europe - Regulatory Affairs Conference 2026

‍

The regulatory landscape for medicines is standing at a major crossroads. From 26–27 February 2026, the Medicines for Europe Regulatory Affairs Conference in Amsterdam will address the industry’s most critical questions: What changes can we expect in the pharmaceutical environment in the years ahead? And how do we transition smoothly to modern methods of patient access?

‍

As the industry faces years of implementation and adaptation following the outcome of new pharmaceutical legislation, this conference comes at a pivotal moment. The agenda is packed with topics that go to the heart of what we do at ACCURIDS—specifically the digitalisation of regulatory processes and the demand for high-quality, interoperable data.

‍

Key Themes & Our Solution: EMA PMS Compliance

‍We are particularly focused on the discussions surrounding the digital transformation of regulatory affairs. With the upcoming decommissioning of the Art 57 database (XEVMPD) and the mandatory shift toward PMS data enrichment, companies are facing a complex data challenge.

‍

At ACCURIDS, we aren’t just observing these changes—we are actively solving them. We understand that this transition is not merely a compliance check but a fundamental shift in how you manage your product data. That is why we have developed our EMA PMS Compliance Solution.

‍

Enabled by our IDMP Data Standardization Fabric, our solution allows you to:

• Automate Alignment: Automatically compare your internal data (from Veeva, RIM, etc.) side-by-side with the EMA dataset.
• Identify Discrepancies: Use AI-enabled proposals to find and fix data errors instantly.
• Ensure Readiness: Achieve full alignment with EMA PMS well before the regulatory deadlines.

‍

This "clean up" of data is the essential first step to successfully navigating the decommissioning of XEVMPD and the implementation of the EMA & HMA Strategy 2028.

‍

Let’s Connect in Amsterdam

‍Connect with Raphael Sergent (raphael.sergent@accurids.com), our Head of QA & Pharma Solutions Lead, who will be present for the duration of the event.

‍

Raphael is eager to share views on how companies can prepare for these new challenges and demonstrate how our solution can eliminate the risk and complexity of your IDMP project. If you are looking to discuss the future of IDMP, the co-existence of ASMF certification and CEP, or simply need a strategy for your PMS data alignment, he is the right person to talk to.

‍

Looking Ahead

‍The next five years in Regulatory Affairs will be defined by how well we adapt to these "horizontal environmental legislations" and digital mandates. We believe that with the right data strategy—and the right compliance tools—these regulatory hurdles can be transformed into opportunities for greater efficiency and security of supply.

‍

We look forward to seeing you in Amsterdam to shape the future of regulatory affairs together!